arrow
M

Michael E. Ward

national institute of neurological disorders and stroke
H指数:72
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Temporal proteomic and phosphoproteomic dynamics during neuronal differentiation in the reference iPSC line KOLF2.1J

在参考iPSC系KOLF2.1J中神经元分化期间的时序蛋白质组学和磷酸化蛋白质组学动态。

2026-02-240
PRE
TDP-43 loss induces cryptic polyadenylation in ALS/FTD

TDP-43丢失诱导ALS/FTD中隐藏的聚腺苷酸化

2025-10-210
OAAI
Maintenance of neuronal TDP-43 expression requires axonal lysosome transport

神经元TDP-43表达的维持需要轴突溶酶体运输

2025-09-190
OA
Mechanism of cytarabine-induced neurotoxicity

阿糖胞苷的神经毒性机制

Nature
IF48.5
2025-06-250
PRE
Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer's disease

AL002的临床前期和首次人体评估,这是一种用于阿尔茨海默氏病的新型TREM2激动性抗体

2024-10-233
OAAI
HDGFL2 cryptic proteins report presence of TDP-43 pathology in neurodegenerative diseases (vol 19, 29, 2024)
2024-07-270
OAAI
Frontotemporal lobar degeneration targets brain regions linked to expression of recently evolved genes

额颞叶变性的目标是与最近进化基因表达相关的大脑区域

BRAIN
IF11.7
2024-06-281
OAAI
An ANXA11 P93S variant dysregulates TDP-43 and causes corticobasal syndrome

ANXA11 P93S变体异常调节TDP-43并导致皮质基底综合征

2024-06-260
OA
HDGFL2 cryptic proteins report presence of TDP-43 pathology in neurodegenerative diseases
2024-03-274
OAAI
Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD

错误剪接的转录本在TDP-43-related ALS/FTD中产生新生蛋白

2024-02-1420
OA
TMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia
2024-01-1710
OA